New stock first day | Huarong Biotechnology-B (02396.HK) first listed, opened 11.52% lower in early trading. The company is a leading Chinese PDGF drug biopharmaceutical enterprise.

According to the Securities Times APP, Huarui Biotech-B (02396.HK) has made its debut on the stock market. The announcement shows that the price per share is 38.2 Hong Kong dollars, with a total of 17.6488 million shares issued, and 200 shares per lot. The net proceeds are approximately 600 million Hong Kong dollars. As of the time of writing, the stock has fallen by 11.52% to 33.8 Hong Kong dollars, with a trading volume of 1.03 billion Hong Kong dollars.